Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2018-02-15 04:46 2018-02-12 BH N/A BIGLARI, SARDAR Director, 10% owner Other BUY $403.85 3,663 $1,479,310 712,624 +0.5%
2018-02-15 00:09 2018-02-12 MB N/A Luxor Capital Group, LP 10% owner Other BUY $31.36 43,000 $1,348,459 541,724 +8.6%
2018-02-15 01:38 2018-02-12 POST Post Holdings, Inc. STIRITZ WILLIAM P Director Grain Mill Products BUY $71.99 100,000 $7,199,380 1,512,362 +7.1%
2018-02-15 02:03 2018-02-12 COTY COTY INC. JAB Cosmetics B.V. 10% owner Perfumes, Cosmetics & Other Toilet Preparations BUY $20.60 4,100,000 $84,475,170 290,108,041 +1.4%
2018-02-14 01:38 2017-11-21 SCPH N/A Agger Mette Kirstine Director, 10% owner Other BUY $14.00 654,762 $9,166,668 3,183,986 +25.9%
2018-02-14 00:59 2018-02-13 MGEN Viridian Therapeutics, Inc.\DE Booth Bruce Director Pharmaceutical Preparations BUY $5.50 545,454 $2,999,997 1,351,090 +67.7%
2018-02-14 02:49 2018-02-09 KKR KKR & Co. Inc. ValueAct Holdings, L.P. 10% owner Investment Advice BUY $21.03 500,000 $10,517,000 49,700,000 +1.0%
2018-02-14 00:01 2018-02-09 PSEC PROSPECT CAPITAL CORP Barry John F Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER Other BUY $6.73 467,178 $3,144,482 33,259,333 +1.4%
2018-02-14 00:59 2018-02-09 TNDM TANDEM DIABETES CARE INC ROEDER DOUGLAS A Director Surgical & Medical Instruments & Apparatus BUY $2.00 1,000,000 $2,000,000 13,217 +100.0%
2018-02-14 00:52 2018-02-09 TNDM TANDEM DIABETES CARE INC BLICKENSTAFF KIM D Director, Officer - PRESIDENT & CEO Surgical & Medical Instruments & Apparatus BUY $2.00 750,000 $1,500,000 1,236,494 +154.2%
2018-02-13 22:30 2018-02-12 GLPI Gaming & Leisure Properties, Inc. CLIFFORD WILLIAM J Officer - SVP, CFO and Treas Real Estate Investment Trusts BUY $33.00 85,000 $2,805,000 351,068 +31.9%
2018-02-13 22:29 2018-02-12 GLPI Gaming & Leisure Properties, Inc. CARLINO PETER M Director, Officer - Chairman,CEO,President Real Estate Investment Trusts BUY $33.33 40,000 $1,333,200 4,388,089 +0.9%
2018-02-14 03:02 2018-02-09 HK BATTALION OIL CORP ARES MANAGEMENT LLC Director, 10% owner Crude Petroleum & Natural Gas BUY $6.90 1,113,466 $7,682,915 21,855,284 +5.4%
2018-02-14 01:08 2018-02-09 SMPL Simply Good Foods Co KILTS JAMES M Director Food and Kindred Products BUY $12.40 651,360 $8,076,864 658,860 +8,684.8%
2018-02-13 00:31 2018-02-08 INSE Inspired Entertainment, Inc. HG Vora Capital Management, LLC 10% owner Services-Prepackaged Software BUY $5.15 1,243,500 $6,404,025 4,150,000 +42.8%
2018-02-13 03:17 2018-02-08 BW Babcock & Wilcox Enterprises, Inc. STEEL PARTNERS HOLDINGS L.P. 10% owner Heating Equipment, Except Electric & Warm Air Furnaces BUY $5.66 441,456 $2,500,318 5,621,962 +8.5%
2018-02-13 00:54 2018-02-09 RDUS N/A BIOTECH GROWTH N V 10% owner Other BUY $34.38 75,000 $2,578,763 5,773,799 +1.3%
2018-02-13 00:23 2018-02-08 VCTR Victory Capital Holdings, Inc. HAWKES JAMES B Director Investment Advice BUY $12.66 335,000 $4,239,995 90,000 +100.0%
2018-02-12 23:44 2017-11-09 GGO-A N/A GABELLI MARIO J Director, 10% owner, Other Other BUY $43.50 131,956 $5,740,086 131,956 +100.0%
2018-02-13 03:12 2018-02-08 ONTX Traws Pharma, Inc. TYNDALL CAPITAL PARTNERS L P 10% owner Pharmaceutical Preparations BUY $1.01 1,100,000 $1,111,000 2,097,022 +110.3%
2018-02-13 05:59 2018-02-09 CTIC N/A BVF PARTNERS L P/IL 10% owner Other BUY $3.00 6,333,333 $18,999,999 1,295,582 +100.0%
2018-02-13 00:45 2018-02-12 GRA N/A FESTA ALFRED E Director, Officer - Chairman and CEO Other BUY $65.38 25,000 $1,634,500 268,935 +10.2%
2018-02-13 04:00 2017-12-19 HPPI Inhibitor Therapeutics, Inc. Cross Stefan Director Pharmaceutical Preparations BUY $162,660.00 600,000 $97,596,000,000 0 +100.0%
2018-02-13 03:47 2017-12-19 HPPI Inhibitor Therapeutics, Inc. Mayne Pharma Ventures Pty Ltd 10% owner Pharmaceutical Preparations BUY $162,660.00 600,000 $97,596,000,000 198,106,132 +0.3%
2018-02-09 18:34 2018-01-29 EYEN HYPERION DEFI, INC. Yoshida Shuhei Director, 10% owner Pharmaceutical Preparations BUY $10.00 100,000 $1,000,000 1,718,566 +6.2%
2018-02-09 18:25 2018-01-29 EYEN HYPERION DEFI, INC. Senju Pharmaceutical Co., Ltd. 10% owner Pharmaceutical Preparations BUY $10.00 100,000 $1,000,000 1,718,566 +6.2%
2018-02-10 04:08 2018-02-07 BH N/A BIGLARI, SARDAR Director, 10% owner Other BUY $394.12 3,547 $1,397,960 708,961 +0.5%
2018-02-08 21:30 2017-12-29 FZMD Fuse Medical, Inc. Brooks Mark W Director, 10% owner Wholesale-Medical, Dental & Hospital Equipment & Supplies BUY $0.20 50,000,000 $10,000,000 55,000,000 +1,000.0%
2018-02-08 22:58 2016-12-29 FZMD Fuse Medical, Inc. NC 143 Family Holdings, LP 10% owner Wholesale-Medical, Dental & Hospital Equipment & Supplies BUY $0.20 50,000,000 $10,000,000 55,000,000 +1,000.0%
2018-02-09 02:44 2018-02-06 KKR KKR & Co. Inc. ValueAct Holdings, L.P. 10% owner Investment Advice BUY $21.55 1,450,000 $31,244,020 49,200,000 +3.0%
2018-02-09 02:00 2018-02-06 OSIS OSI SYSTEMS INC LUSKIN MEYER/ Director Semiconductors & Related Devices BUY $56.79 20,000 $1,135,700 28,446 +236.8%
2018-02-09 01:00 2018-02-06 AON Aon plc KNIGHT LESTER B Director Insurance Agents, Brokers & Service BUY $138.42 60,000 $8,305,302 85,000 +240.0%
2018-02-08 00:27 2018-02-05 KRG KITE REALTY GROUP TRUST BINDLEY WILLIAM E Director Real Estate Investment Trusts BUY $15.06 100,000 $1,505,840 163,934 +156.4%
2018-02-07 17:20 2018-02-06 LKFN LAKELAND FINANCIAL CORP WELCH M SCOTT Director State Commercial Banks BUY $45.64 25,000 $1,140,968 127,798 +24.3%
2018-02-08 02:38 2014-05-14 MBII N/A WADDELL & REED FINANCIAL INC 10% owner, Other Other BUY $9.45 2,753,509 $26,021,761 4,768,092 +136.7%
2018-02-07 01:53 2018-02-02 OCN ONITY GROUP INC. COOPERMAN LEON G 10% owner Mortgage Bankers & Loan Correspondents BUY $3.17 1,524,913 $4,836,414 5,777,968 +35.9%
2018-02-06 18:36 2018-02-05 VSI N/A SHAH CAPITAL MANAGEMENT 10% owner Other BUY $3.83 300,000 $1,149,000 4,120,000 +7.9%
2018-02-07 02:36 2018-02-02 LGCY N/A Baines Creek Capital, LLC 10% owner Other BUY $2.27 526,000 $1,194,967 9,571,146 +5.8%
2018-02-07 04:37 2018-02-02 BH N/A BIGLARI, SARDAR Director, 10% owner Other BUY $400.56 3,310 $1,325,852 705,414 +0.5%
2018-02-06 18:00 2018-01-29 EYEN HYPERION DEFI, INC. ESHELMAN FREDRIC N Director, 10% owner Pharmaceutical Preparations BUY $10.00 335,000 $3,350,000 1,273,428 +35.7%
2018-02-06 17:41 2018-02-05 MBII N/A ARDSLEY ADVISORY PARTNERS 10% owner, Other Other BUY $0.75 6,666,667 $5,000,000 10,348,247 +181.1%
2018-02-07 00:30 2018-02-02 UFI UNIFI INC Bishop Robert J Director Textile Mill Products BUY $35.22 29,329 $1,032,915 1,294,478 +2.3%
2018-02-05 22:14 2018-02-02 FTSI N/A RRJ CAPITAL LTD 10% owner Other BUY $18.00 560,000 $10,080,000 1,164,291 +92.7%
2018-02-06 00:00 2018-02-01 SGEN N/A BAKER BROS. ADVISORS LP Director, 10% owner Other BUY $52.00 3,846,153 $199,999,956 44,355,335 +9.5%
2018-02-06 00:43 2018-02-01 MTECU N/A MTech Sponsor LLC 10% owner Other BUY $10.00 225,000 $2,250,000 225,000 +100.0%
2018-02-02 22:58 2018-01-31 BETR N/A HERSHEY CO 10% owner Other BUY $12.00 76,739,908 $920,878,896 1,000 +100.0%
2018-02-02 22:33 2018-01-02 VSI N/A SHAH CAPITAL MANAGEMENT 10% owner Other BUY $4.08 490,000 $2,000,474 34,800 +100.0%
2018-02-03 00:10 2017-12-15 AB AllianceBernstein Holding L.P. AXA Equitable Holdings, Inc. Other Investment Advice BUY $24.95 1,240,983 $30,962,526 2,312,163 +115.9%
2018-02-02 23:53 2018-01-31 SYRS Syros Pharmaceuticals Inc. AKKARAJU SRINIVAS Director Pharmaceutical Preparations BUY $9.55 209,424 $1,999,999 1,059,938 +24.6%
2018-02-03 01:45 2018-01-31 KALA KALA BIO, Inc. ORBIMED ADVISORS LLC 10% owner Pharmaceutical Preparations BUY $15.00 362,240 $5,433,383 3,385,000 +12.0%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.